feed,title,long_url,short_url
Preprints,Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients,https://www.preprints.org/manuscript/202301.0359/v1,https://da.gd/ftzaek
